OncoTargets and Therapy
Volume 11, 2018 - Issue
Open access
77
Views
4
CrossRef citations to date
0
Altmetric
Review
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
Jie Hua1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Si Shi1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Dingkong Liang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Chen Liang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Qingcai Meng1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Bo Zhang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Quanxing Ni1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]
, Jin Xu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]Correspondence[email protected] [email protected]
& Xianjun Yu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China, [email protected]; [email protected];2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];3 Pancreatic Cancer Institute, Fudan University, Shanghai, People’s Republic of China, [email protected]; [email protected];4 Shanghai Pancreatic Cancer Institute, Shanghai, People’s Republic of China, [email protected]; [email protected]Correspondence[email protected] [email protected]
show all
Pages 4591-4608
|
Published online: 06 Aug 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.